Clomipramine Hydrochloride recalls

Clomipramine Hydrochloride products have been recalled 6 times, most recently on 12 Nov 2025. The recalling company is usually Zydus Pharmaceuticals (USA). The most common reason is nitrosamine impurity.

Total recalls6since 2022
Last 12 months3reported
Class I00% of total
Ongoing3latest 12 Nov 2025

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 5 83%Class III 1 17%

Why clomipramine hydrochloride is recalled

By year

Ongoing clomipramine hydrochloride recalls

3 active
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIclomiPRAMINE Hydrochloride, Capsules, USP, 75 mg recalledClomipramine HydrochlorideZydus Pharmaceuticals (USA)Nitrosamine ImpurityNationwide
DrugCLASS IIclomiPRAMINE Hydrochloride, Capsules, USP, 50 mg recalledClomipramine HydrochlorideZydus Pharmaceuticals (USA)Nitrosamine ImpurityNationwide
DrugCLASS IIclomiPRAMINE Hydrochloride, Capsules, USP, 25 mg recalledClomipramine HydrochlorideZydus Pharmaceuticals (USA)Nitrosamine ImpurityNationwide

All clomipramine hydrochloride recalls, newest first

6 total

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.